BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 38710733)

  • 1. Development and validation of high-performance liquid chromatography method for the simultaneous quantification of rivastigmine hydrogen tartrate and asiaticoside co-loaded in niosomes: A Box-Behnken design approach.
    Hnin HM; Tun T; Jansook P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jul; 1241():124170. PubMed ID: 38805871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematical approach in evaluation of LC method for determination of raloxifene hydrochloride and its impurities employing experimental design.
    Jančić Stojanović B; Rakić T; Slavković B; Kostić N; Vemić A; Malenović A
    J Pharm Anal; 2013 Feb; 3(1):45-52. PubMed ID: 29403795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilizing experimental design and desirability function in optimizing RP-HPLC method for simultaneous determination of some skeletal muscle relaxants and analgesics.
    Mozayad AN; Fouad MA; Elkady EF
    Sci Rep; 2024 May; 14(1):10360. PubMed ID: 38710733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Aspirin, Prasugrel and Clopidogrel in Counterfeit Pharmaceutical and Herbal Products: Plackett-Burman Screening and Box-Behnken Optimization.
    Mohammad MA; Elkady EF; Fouad MA; Salem WA
    J Chromatogr Sci; 2021 Aug; 59(8):730-747. PubMed ID: 33367531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plackett-Burman and face-centered composite designs for development and optimization of chromatographic method for the simultaneous determination of glycopyrronium, indacaterol and mometasone in their fixed dose combination inhaler - Green profile assessment.
    Youssef YM; Mahrouse MA; Mostafa EA
    J Pharm Biomed Anal; 2023 Sep; 234():115553. PubMed ID: 37399700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In depth investigation of the retention behavior of structurally related β-blockers on RP-HPLC column: Quality by design and quantitative structure-property relationship complementary approaches for optimization and validation.
    Hakiem AFA; Hamdy AK; Ali HRH; Gomaa M; Aboraia AS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Mar; 1166():122549. PubMed ID: 33545562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Box-Behnken Design and Response Surface Methodology for Selecting the Optimum RP-HPLC Conditions for the Simultaneous Determination of Paracetamol and Diclofenac Sodium Along With Three Skeletal Muscle Relaxants in Three Different Pharmaceutical Dosage Forms.
    Elkady E; Fouad M; Mozayad A
    J Chromatogr Sci; 2024 Apr; 62(4):328-338. PubMed ID: 37525524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of Box-Behnken experimental design and response surface methodology for selecting the optimum RP-HPLC conditions for the simultaneous determination of methocarbamol, indomethacin and betamethasone in their pharmaceutical dosage form.
    Elkady EF; Fouad MA; Mozayad AN
    BMC Chem; 2022 Dec; 16(1):114. PubMed ID: 36510282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemometric-Based AQbD and Green Chemistry Approaches to Chromatographic Analysis of Remogliflozin Etabonate and Vildagliptin.
    Prajapati P; Ahir H; Prajapati B; Shah S
    J AOAC Int; 2022 Dec; 106(1):239-249. PubMed ID: 35822588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DoE Screening and Optimization of Liquid Chromatographic Determination of Nicotinic Acid and Six Statins: Application to Pharmaceutical Preparations and Counterfeit Detection.
    Salem WA; Elkady EF; Fouad MA; Mohammad MA
    J Chromatogr Sci; 2022 Dec; 61(1):74-86. PubMed ID: 34894146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Metformin and Five Gliptins in Counterfeit Herbal Products: Designs of Experiment Screening and Optimization.
    Salem WA; Elkady EF; Fouad MA; Abdul-Azim Mohammad M
    J AOAC Int; 2021 Dec; 104(6):1667-1680. PubMed ID: 34410406
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.